Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Clearing Things Up: When to Consider 'Accutane' for Serious Acne

Jie Chen, RPA-C with Advanced Dermatology PC, Shares Tips on Isotretinoin Treatment.


News provided by

Advanced Dermatology PC

Oct 25, 2018, 08:30 ET

Share this article

Share toX

Share this article

Share toX

Jie Chen, RPA-C
Jie Chen, RPA-C

EAST SETAUKET, N.Y., Oct. 25, 2018 /PRNewswire-PRWeb/ -- If only acne's damage stayed skin deep. "For some patients, it's much more noticeable," says Jie Chen, a certified registered physician's assistant specializing in dermatology with Advanced Dermatology PC. "Persistent, serious 'problem skin' can cause disfigurement that can lead to depression. Especially for young people, unremitting acne can result in erosion of self esteem and create long-lasting emotional scars."

Acne is one of the most common skin problems: The American Academy of Dermatology (AAD) reports that as many as 50 million people have some level of the condition, the result of factors such as hormones, genetics, and stress.

Isotretinoin offers a remarkable level of relief from severe acne. But it’s essential that patients are fully aware of and comfortable with what treatment entails.

Post this

"A pimple pops up when our skin's natural regeneration is disrupted," explains Chen. "If pores get clogged with sebum skin oil, then dead skin cells can't be expelled. Fortunately, we have over-the-counter products to clear up the pimples caused by milder forms of acne."

More severe forms are tied to the naturally occurring skin bacteria for which problem skin is named: p. acnes. "Serious acne occurs when more of the bacteria p. acnes gets trapped, causing deeper levels of inflammation," Chen continues. "As a result, pimples can merge, affecting larger sections of skin. And, at its worst, persistent, painful nodules develop."

"With serious acne," Chen emphasizes, "OTC treatments are limited and permanent scarring can result." The first step to recovering from serious acne is to see a dermatologist: "We have very effective prescription treatments for serious acne," says Chen, "including isotretinoin."

Isotretinoin entered the dermatologist's medicine cabinet in 1982, when it was approved as the brand Accutane. Today, the oral retinoid-based medicine is offered under other brands, including Amnesteen and Claravis.

"This is serious treatment for serious acne," Chen notes. "It's extremely effective because it addresses all of the root causes, including the extreme levels of inflammation. Over the last 36 years, millions of acne sufferers have had their severe acne clear up. That said, patients need to be fully aware of certain considerations and side effects."

Chen offers the following 6 tips to patients considering isotretinoin:

1. The Rx "small print" is a big deal: "Isotretinoin can interfere with fetal development, resulting in birth defects," says Chen. "The FDA requires both doctors and patients to participate in a program called iPLEDGE. For women of childbearing age, this includes using two forms of birth control and pregnancy testing. Also, in terms of side effects, check-ups may be needed to monitor liver enzymes and lipid levels, as they can be affected."

2. Monitor how you feel and keep your doctor informed: "Some patients have reported that isotretinoin caused their depression or inflammatory bowel disease," states Chen. "At this point, research hasn't established a clear link with either. This year, the AAD reaffirmed its support for isotretinoin, as long as patients are aware of the possible risks and doctors monitor the situation." Chen adds that some patients complain about lower back pain and vision change.

3. Stay proactive to minimize side effects: "During treatment, isotretinoin can dry out the skin and cause sun sensitivity," notes Chen. "Don't wait for problems to occur. From the start of treatment, patients should moisturize daily and drink plenty of water, as well as be sure to use sunscreen."

4. Don't be alarmed if at first your acne flares: "In some cases, patients see an initial spike in their symptoms," notes Chen. "You can also talk with your doctor about starting off at a lower dose to acclimate."

5. Take as directed: "Make sure that you follow your doctor's instructions," says Chen. "For example, for optimal absorption, it's important to take it with a full meal." Chen adds that patients are advised to not take over the counter vitamin A when taking Isotretinoin.

6. Stay the course: "Isotretinoin is extremely effective at clearing up acne," Chen explains, "but a key goal of treatment is also to hopefully prevent any reoccurrence. The research here is quite clear: patients need to reach a certain level of cumulative medication. A patient who stops early is more likely to have a relapse."

"Isotretinoin offers a remarkable level of relief from severe acne," Chen concludes. "But it's essential that patients are fully aware of and comfortable with what treatment entails."

Bio: Jie Chen, RPA-C is a board certified physician assistant with Advanced Dermatology PC. She has a master's degree in physician assistant studies.

Advanced Dermatology P.C. and the Center for Laser and Cosmetic Surgery (New York & New Jersey) is one of the leading dermatology centers in the nation, offering highly experienced physicians in the fields of cosmetic and laser dermatology as well as plastic surgery and state-of-the-art medical technologies. http://www.advanceddermatologypc.com.

SOURCE Advanced Dermatology PC

Related Links

http://www.advanceddermatologypc.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.